Armistice Capital, LLC discloses 6.3% stake in Voyager Therapeutics
Voyager Therapeutics
- 6.3%[1]
Armistice Capital, LLC reported a 6.3% stake in Voyager Therapeutics (VYGR) in a Schedule 13G filed with the SEC on Nov 16, 2026. The filing covers 3,872,000 shares and raises its earlier 1.3% stake.[1]
| Reporting person | Security | Shares | Ownership | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | Voyager Therapeutics, Inc | 3,872,000 | 6.3% | 2026-11-16 |
What is a Schedule 13G?
A Schedule 13G is a passive-holder filing. Holders above five percent of a class must file one. It reports ownership, not a trade price.[1]
How did the stake change?
Armistice Capital, LLC reported 1.3% in its earlier filing and 6.3% now.[1]
What does this filing not show?
The form shows ownership on its cover page. It does not show what the holder paid or what it plans to do next.[1]